Home › Merck & Co., Inc. (MRK) Price Target Lowered to $65.00 at Argus
 

Keywords :   


Merck & Co., Inc. (MRK) Price Target Lowered to $65.00 at Argus

2015-11-30 07:37:30| Biotech - Topix.net

The firm presently has a "buy" rating on the stock. Argus' price target indicates a potential upside of 20.46% from the company's current price.

Tags: to price target lowered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »